Cover Image
市場調查報告書

全球手術專用創傷護理產品市場 2016年:外科用密封膠,黏劑,吸收性止血劑及粘連防止產品

2016 Global Markets for Specialty Surgical Wound Care Products: Surgical Sealants, Glues, Absorbable Hemostats, and Adhesion Prevention Products

出版商 Life Science Intelligence, Inc. 商品編碼 278727
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
全球手術專用創傷護理產品市場 2016年:外科用密封膠,黏劑,吸收性止血劑及粘連防止產品 2016 Global Markets for Specialty Surgical Wound Care Products: Surgical Sealants, Glues, Absorbable Hemostats, and Adhesion Prevention Products
出版日期: 2016年01月29日 內容資訊: 英文
簡介

包含密封膠、黏劑、吸收性止血劑及粘連防止產品的全球手術專用創傷護理產品市場規模,2014年是32億美金。影響該市場成長的主要原因,為手術數量的增加,全球收益預計至2020年達到44億美元。

本報告提供全球手術專用創傷護理產品市場相關調查,地各區及各產品類型的市場分析與預測,供應商的佔有率分析等彙整,為您概述為以下內容。

市場模式

第1章

  • 全球外科用密封膠,黏劑,吸收性止血劑及粘連防止產品市場:各產品類型
  • 全球外科用密封膠,黏劑,吸收性止血劑及粘連防止產品市場:各地區
  • 美國的外科用密封膠,黏劑,吸收性止血劑及粘連防止產品市場:各產品類型
  • 歐洲的外科用密封膠,黏劑,吸收性止血劑及粘連防止產品市場:各產品類型
  • 亞太地區 (AP) & 其他 (ROW) 的外科用密封膠,黏劑,吸收性止血劑及粘連防止產品市場:各產品類型
  • 全球供應商佔有率

第2章

  • 全球外科用密封膠,黏劑,吸收性止血劑及粘連防止產品市場:各產品類型
  • 全球外科用密封膠,黏劑,吸收性止血劑及粘連防止產品市場:各地區
  • 美國的外科用密封膠,黏劑,吸收性止血劑及粘連防止產品市場:各產品類型
  • 美國的對象手術的處理數量
  • 美國的外部、內部組織密封膠市場預測
  • 美國的外科用黏劑市場預測
  • 美國的外科用黏劑,核准 & 非標籤藥物用 (非適應症使用) 市場預測
  • 美國的吸收性止血劑市場預測
  • 美國的粘連防止產品市場預測
  • 美國供應商的佔有率
  • 歐洲的對象手術的處理數量
  • 歐洲的外部、內部組織密封膠市場預測
  • 歐洲的外科用黏劑市場預測
  • 歐洲的外科用黏劑,核准 & 非標籤藥物用 (非適應症使用) 市場預測
  • 歐洲的吸收性止血劑市場預測
  • 歐洲的粘連防止產品市場預測
  • AP & ROW 的對象手術的處理數量
  • AP & ROW 的外部、內部組織密封膠市場預測
  • AP & ROW 的外科用黏劑市場預測
  • AP & ROW 的外科用黏劑,核准 & 非標籤藥物用 (非適應症使用) 市場預測
  • AP & ROW 的吸收性止血劑市場預測
  • AP & ROW 的粘連防止產品市場預測
  • OUS供應商的佔有率

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: LSI-WW151WO

About the global market:

The global market for specialty surgical wound care products-which includes sealants, glues, absorbable hemostats, and adhesion prevention products-was valued at $3.2 billion in 2014. The main factor influencing growth in the market is surgical volumes; rising numbers of surgeries in major global markets will generate greater revenues through 2020, when total sales are projected to reach $4.4 billion. Sales of absorbable hemostats and adhesion prevention products are expected to increase at the swiftest rates, followed by surgical glues and sealants.

Factors driving growth through 2020 include the following:

  • 1. Rising surgical volumes due to greater access to healthcare in the U.S. and emerging markets. Favorable demographics in mature markets such as Japan and Western Europe should generate mild increases in annual caseloads;
  • 2. Growing utilization in emerging markets and important surgical applications, such as cardiothoracic surgery and neurosurgery; and
  • 3. New product introductions which will help to sustain pricing levels.

Factors limiting growth through 2020 include the following:

  • 1. Cost-containment efforts in key regional markets, such as Europe, which should lead to price erosion;
  • 2. Important shifts in surgical technique, such as the rising use of laparoscopy in gastrointestinal surgery; and
  • 3. The relative maturity of important segments, such as surgical glues for open surgical repairs of the aorta, carotid, and femoral arteries.

Leading suppliers to the global market include Ethicon (Johnson & Johnson); Baxter International; Genzyme (Sanofi-Aventis); Takeda Pharmaceuticals International; King Pharmaceuticals (Pfizer); The Medicines Company; Integra LifeSciences; and CryoLife. Other suppliers included CSL Behring; Davol, Neomend, and Medafor (C.R. Bard); HemCon Medical Technologies; Hyperbranch Medical Technology; MAST Biosurgery; Orthovita (Stryker); Tenaxis Medical; ThermoGenesis; Tissuemed; and Vivostat A/S.

Companies covered

The following companies are covered in this report:

  • 1. Baxter International
  • 2. CryoLife
  • 3. CSL Behring
  • 4. Davol
  • 5. Ethicon (Johnson & Johnson)
  • 6. Genzyme (Sanofi-Aventis)
  • 7. HemCon Medical Technologies
  • 8. Hyperbranch Medical Technology
  • 9. Integra LifeSciences
  • 10. King Pharmaceuticals (Pfizer)
  • 11. MAST Biosurgery
  • 12. Medafor (C.R. Bard)
  • 13. Neomend
  • 14. Orthovita (Stryker)
  • 15. Takeda Pharmaceuticals International
  • 16. Tenaxis Medical
  • 17. ThermoGenesis
  • 18. Tissuemed
  • 19. Vivostat A/S
  • 20. Zymogenetics (Bristol-Myers Squibb)

Table of Contents

Market Models

  • Market Model 1-1: The Global Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type
  • Market Model 1-2: The Global Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Region
  • Market Model 1-3: The U.S. Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type
  • Market Model 1-4: The European Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type
  • Market Model 1-5: The AP & ROW Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type
  • Market Model 1-6: Global Supplier Shares in 2013 and 2014
  • Market Model 2-1: The Global Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type
  • Market Model 2-2: The Global Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Region
  • Market Model 2-3: The U.S. Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type
  • Market Model 2-4: Targeted Surgical Caseloads in the U.S. from 2013-2020
  • Market Model 2-5: The U.S. Market Forecast for External and Internal Tissue Sealants from 2013-2020
  • Market Model 2-6: The U.S. Market Forecast for Surgical Glues from 2013-2020
  • Market Model 2-7: The U.S. Market Forecast for Surgical Glues, Approved & Off-Label Uses, from 2013-2020
  • Market Model 2-8: The U.S. Market Forecast for Absorbable Hemostats from 2013-2020
  • Market Model 2-9: The U.S. Market Forecast for Adhesion Prevention Products from 2013-2020
  • Market Model 2-10: U.S. Supplier Shares in 2013 and 2014
  • Market Model 2-11: The European Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type
  • Market Model 2-12: Targeted Surgical Caseloads in Europe from 2013-2020
  • Market Model 2-13: The European Market Forecast for Surgical Sealants from 2013-2020
  • Market Model 2-14: The European Market Forecast for External and Internal Tissue Sealants from 2013-2020
  • Market Model 2-15: The European Market Forecast for Surgical Glues from 2013-2020
  • Market Model 2-16: The European Market Forecast for Surgical Glues from 2013-2020: Open Repairs of the Large Vessels & Other Indications
  • Market Model 2-17: The European Market Forecast for Absorbable Hemostats from 2013-2020
  • Market Model 2-18: The European Market Forecast for Adhesion Prevention Products from 2013-2020
  • Market Model 2-19: The AP & ROW Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type
  • Market Model 2-20: Targeted Surgical Caseloads in AP & ROW Countries from 2013-2020
  • Market Model 2-21: The AP & ROW Market Forecast for Surgical Sealants from 2013-2020
  • Market Model 2-22: The AP & ROW Market Forecast for External and Internal Tissue Sealants from 2013-2020
  • Market Model 2-23: The AP & ROW Market Forecast for Surgical Glues from 2013-2020
  • Market Model 2-24: The AP & ROW Market Forecast for Surgical Glues from 2013-2020: Open Repairs of the Large Vessels & Other Indications
  • Market Model 2-25: The AP & ROW Market Forecast for Absorbable Hemostats from 2013-2020
  • Market Model 2-26: The AP & ROW Market Forecast for Adhesion Prevention Products from 2013-2020
  • Market Model 2-27: OUS Supplier Shares in 2013 and 2014
Back to Top